For example, G protein-coupled estrogen receptor (GPER) signaling was reported to suppress tumor growth and to increase anti-PD-1 immune checkpoint blockade efficacy in a female melanoma mouse model3, whereas sustained AR signaling was reported to promote melanoma aggressiveness4,5 and resistance to targeted therapies6. The gene discussed is AR; the disease is neoplasm.